Basilea Pharmaceutica AG
SIX:BSLN.SW
43.2 (CHF) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 157.634 | 147.765 | 148.122 | 127.629 | 134.381 | 132.555 | 101.521 | 65.984 | 52.825 | 42.499 | 40.951 | 58.336 | 66.15 | 115.555 | 26.828 | 11.974 | 7.898 | 7.184 | 30.495 | 0.287 | 0.379 | 0.204 |
| Cost of Revenue
| 26.794 | 26.803 | 24.072 | 24.054 | 18.868 | 125.241 | 64.08 | 53.796 | 60.075 | 54.377 | 53.349 | 4.398 | 2.366 | 0 | 1.63 | 0.279 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 130.84 | 120.962 | 124.05 | 103.575 | 115.513 | 7.314 | 37.441 | 12.188 | -7.25 | -11.878 | -12.399 | 53.937 | 63.784 | 115.555 | 25.198 | 11.695 | 7.898 | 7.184 | 30.495 | 0.287 | 0.379 | 0.204 |
| Gross Profit Ratio
| 0.83 | 0.819 | 0.837 | 0.812 | 0.86 | 0.055 | 0.369 | 0.185 | -0.137 | -0.279 | -0.303 | 0.925 | 0.964 | 1 | 0.939 | 0.977 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 77.852 | 73.804 | 93.157 | 97.41 | 102.662 | 105.142 | 55.355 | 49.049 | 67.275 | 70.077 | 53.349 | 58.863 | 70.048 | 56.047 | 77.241 | 97.408 | 115.695 | 82.801 | 72.395 | 68.921 | 50.034 | 57.21 |
| General & Administrative Expenses
| 33.783 | 30.815 | 29.721 | 29.422 | 0 | 31.409 | 53.139 | 56.077 | 54.235 | 30.087 | 21.313 | 45.923 | 51.685 | 79.437 | 69.159 | 66.793 | 28.986 | 12.527 | 8.94 | 7.084 | 6.229 | 5.816 |
| Selling & Marketing Expenses
| 0 | 30.815 | 29.721 | 29.422 | 30.051 | 31.409 | 53.139 | 0.2 | 0.3 | 0.1 | 21.313 | 45.923 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 33.783 | 30.815 | 29.721 | 29.422 | 30.051 | 30.471 | 51.577 | 56.077 | 54.235 | 30.087 | 21.313 | 45.923 | 51.685 | 79.437 | 69.159 | 66.793 | 28.986 | 12.527 | 8.94 | 7.084 | 6.229 | 5.816 |
| Other Expenses
| -1.935 | 0.81 | -1.236 | 0 | 0 | 0.938 | 0 | 0 | 0 | 0 | 0 | 0 | -0.699 | -127.615 | 0 | 0.117 | -0.313 | -0.214 | 0 | -1.073 | -0.964 | -0.618 |
| Operating Expenses
| 111.635 | 104.619 | 122.878 | 126.832 | 132.713 | 31.946 | 49.814 | 56.763 | 54.276 | 30.006 | 20.887 | 104.785 | 121.034 | 7.869 | 146.399 | 164.201 | 144.368 | 95.114 | 81.335 | 76.005 | 56.262 | 63.026 |
| Operating Income
| 19.205 | 16.343 | 1.172 | -23.257 | -17.2 | -23.157 | -14.136 | -43.889 | -61.485 | -41.83 | -33.286 | -50.848 | -57.25 | 107.686 | -121.201 | -152.506 | -136.469 | -87.931 | -50.84 | -75.718 | -55.883 | -62.822 |
| Operating Income Ratio
| 0.122 | 0.111 | 0.008 | -0.182 | -0.128 | -0.175 | -0.139 | -0.665 | -1.164 | -0.984 | -0.813 | -0.872 | -0.865 | 0.932 | -4.518 | -12.736 | -17.278 | -12.24 | -1.667 | -264.099 | -147.362 | -307.429 |
| Total Other Income Expenses Net
| -8.744 | -4.241 | -7.966 | 8.59 | -5.182 | -8.003 | -4.89 | -7.065 | -0.035 | 0.31 | 0.294 | -1.491 | 0.165 | 0.492 | 0.987 | 8.978 | 9.65 | 2.781 | 1.244 | 0.246 | 0.232 | 3.849 |
| Income Before Tax
| 10.461 | 12.102 | -6.794 | -14.667 | -22.382 | -31.16 | -19.026 | -50.954 | -61.52 | -41.52 | -32.993 | -52.339 | -57.086 | 108.178 | -120.214 | -143.528 | -126.82 | -85.15 | -49.596 | -75.472 | -55.651 | -58.973 |
| Income Before Tax Ratio
| 0.066 | 0.082 | -0.046 | -0.115 | -0.167 | -0.235 | -0.187 | -0.772 | -1.165 | -0.977 | -0.806 | -0.897 | -0.863 | 0.936 | -4.481 | -11.986 | -16.056 | -11.853 | -1.626 | -263.24 | -146.75 | -288.593 |
| Income Tax Expense
| 0.01 | -0.045 | 0.037 | 0.055 | 0.04 | 0.192 | 0.334 | 0.333 | 0.083 | 0.026 | 0.027 | 0.694 | 0.56 | 0.614 | 0.523 | -8.978 | -9.65 | -2.781 | -1.244 | -0.246 | -0.232 | -3.849 |
| Net Income
| 10.451 | 12.147 | -6.831 | -14.722 | -22.422 | -31.352 | -19.36 | -51.287 | -61.603 | -41.546 | -33.02 | -53.033 | -57.646 | 107.564 | -120.736 | -143.528 | -126.82 | -85.15 | -49.596 | -75.472 | -55.651 | -58.973 |
| Net Income Ratio
| 0.066 | 0.082 | -0.046 | -0.115 | -0.167 | -0.237 | -0.191 | -0.777 | -1.166 | -0.978 | -0.806 | -0.909 | -0.871 | 0.931 | -4.5 | -11.986 | -16.056 | -11.853 | -1.626 | -263.24 | -146.75 | -288.593 |
| EPS
| 0.87 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 | -6.09 | -4.17 | -3.4 | -5.53 | -6.01 | 11.19 | -12.61 | -15.02 | -13.97 | -11.04 | -6.66 | -10.86 | -10.71 | -11.71 |
| EPS Diluted
| 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 | -1.79 | -5.07 | -6.09 | -4.17 | -3.4 | -5.53 | -6.01 | 11.19 | -12.61 | -15.02 | -13.97 | -11.04 | -6.66 | -10.86 | -10.71 | -11.71 |
| EBITDA
| 22.682 | 19.44 | 3.626 | -20.967 | -15.561 | -21.405 | -12.245 | -41.67 | -59.158 | -39.539 | -30.571 | -47.206 | -54.374 | 111.72 | -116.248 | -148.384 | -124.115 | -82.184 | -45.869 | -71.187 | -51.131 | -59.451 |
| EBITDA Ratio
| 0.144 | 0.132 | 0.024 | -0.164 | -0.116 | -0.161 | -0.121 | -0.632 | -1.12 | -0.93 | -0.747 | -0.809 | -0.822 | 0.967 | -4.333 | -12.392 | -15.714 | -11.44 | -1.504 | -248.295 | -134.831 | -290.931 |